This is a compelling project. A 70% revenue share for stakers is an exceptionally high number that would normally raise red flags, but it changes the context significantly when you see that the Pharmatech AI team has an established, existing company behind them. This existing structure and the secured $5M investment make the ambitious tokenomics seem more viable and suggest they have the foundation to support it. It's this level of tangible backing that makes me seriously consider an investment, as it feels more substantial than a typical token launch.